Can Bone Marrow Dosimetric Parameters Predict for Myelotoxicity in Cervical Cancer Patients Treated With Concurrent Chemotherapy and Extended-Field Intensity-Modulated Pelvic Radiotherapy (EF-IMRT)?

Authors :: Sushil Beriwal
Ron Lalonde
Gregory N. Gan
Hyun Soo Kim
Dwight E. Heron
Source :: International Journal of Radiation Oncology*Biology*Physics. 69:S395-S396
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Cervical cancer
Cancer Research
medicine.medical_specialty
Radiation
business.industry
Extended field
medicine.disease
Intensity (physics)
Concurrent chemotherapy
medicine.anatomical_structure
Oncology
medicine
Radiology, Nuclear Medicine and imaging
Bone marrow
Radiology
business
Pelvic radiotherapy

Full Text Access

Tools